TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored December 10, 1982
TCL Archive Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it March 17, 1989